A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
被引:1938
作者:
Goodwin, B
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Goodwin, B
Jones, SA
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Jones, SA
Price, RR
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Price, RR
Watson, MA
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Watson, MA
McKee, DD
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
McKee, DD
Moore, LB
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Moore, LB
Galardi, C
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Galardi, C
Wilson, JG
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Wilson, JG
Lewis, MC
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Lewis, MC
Roth, ME
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Roth, ME
Maloney, PR
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Maloney, PR
Willson, TM
论文数: 0引用数: 0
h-index: 0
机构:Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Willson, TM
Kliewer, SA
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USAGlaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
Kliewer, SA
[1
]
机构:
[1] Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA
[2] Glaxo Wellcome Res & Dev Ltd, Dept Metab Dis, Res Triangle Pk, NC 27709 USA
[3] Glaxo Wellcome Res & Dev Ltd, Dept Med Chem, Res Triangle Pk, NC 27709 USA
Bile acids repress the transcription of cytochrome P450 7A1 (CYP7A1), which catalyzes the rate-limiting step in bile acid biosynthesis. Although bile acids activate the farnesoid X receptor (FXR), the mechanism underlying bile acid-mediated repression of CYP7A1 remained unclear. We have used a potent, nonsteroidal FXR ligand to show that FXR induces expression of small heterodimer partner 1 (SHP-1), an atypical member of the nuclear receptor family that lacks a DNA-binding domain. SHP-1 represses expression of CYP7A1 by inhibiting the activity of liver receptor homolog 1 (LRH-1), an orphan nuclear receptor that is known to regulate CYP7A1 expression positively. This bile acid-activated regulatory cascade provides a molecular basis for the coordinate suppression of CYP7A1 and other genes involved in bile acid biosynthesis.